Impedimed Limited Stock Return On Equity

IPDQF Stock  USD 0.06  0.02  26.69%   
ImpediMed Limited fundamentals help investors to digest information that contributes to ImpediMed's financial success or failures. It also enables traders to predict the movement of ImpediMed Pink Sheet. The fundamental analysis module provides a way to measure ImpediMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ImpediMed pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ImpediMed Limited Company Return On Equity Analysis

ImpediMed's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current ImpediMed Return On Equity

    
  -0.52  
Most of ImpediMed's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ImpediMed Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, ImpediMed Limited has a Return On Equity of -0.5192. This is 97.83% lower than that of the Healthcare sector and 94.05% lower than that of the Medical Devices industry. The return on equity for all United States stocks is 67.48% higher than that of the company.

ImpediMed Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ImpediMed's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of ImpediMed could also be used in its relative valuation, which is a method of valuing ImpediMed by comparing valuation metrics of similar companies.
ImpediMed is currently under evaluation in return on equity category among related companies.

ImpediMed Fundamentals

About ImpediMed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ImpediMed Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImpediMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImpediMed Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImpediMed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImpediMed's short interest history, or implied volatility extrapolated from ImpediMed options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImpediMed Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for ImpediMed Pink Sheet analysis

When running ImpediMed's price analysis, check to measure ImpediMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImpediMed is operating at the current time. Most of ImpediMed's value examination focuses on studying past and present price action to predict the probability of ImpediMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImpediMed's price. Additionally, you may evaluate how the addition of ImpediMed to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Please note, there is a significant difference between ImpediMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImpediMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImpediMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.